Related Experiment Video

Updated: Oct 30, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.4K

Peritoneal carcinomatosis and occult metastasis in prostate cancer: [68Ga]PSMA vs [11C]Choline

Angelo Castello1, Paola Caroli2, Egesta Lopci1

  • 1Nuclear Medicine, Humanitas Clinical and Research Hospital - IRCCS, Rozzano, MI, Italy.

Revista Espanola De Medicina Nuclear E Imagen Molecular
|July 5, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.6K
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

10.7K

Related Experiment Videos

Last Updated: Oct 30, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.4K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.6K
Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

10.7K

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

287
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
287
Positron Emission Tomography01:29

Positron Emission Tomography

6.4K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.4K

Articles linked to this work by shared authors, journal, and citation graph.

The Importance of Molecular Imaging Response Criteria: Rationale and Overview.

The British journal of radiology·2026

Post-VABB Cavity-Targeted Avidin-Pretargeted [90Y]Y-DOTA-Biotin in Nonpalpable Breast Cancer: A Phase I Activity-Escalation Study (ARTHE).

Cancers·2026

Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy.

European journal of nuclear medicine and molecular imaging·2026

Prognostic value of plasma thymus- and activationregulated chemokine levels after the second cycle of chemotherapy in pediatric Hodgkin lymphoma.

Haematologica·2026

Molecular, Biochemical, and Bioimaging Markers of MEN Syndromes.

Genes·2026

Choline PET/CT in the PSMA Era: Clinical Repositioning, Biological Perspectives, and Emerging Applications.

Diagnostics (Basel, Switzerland)·2026

Practical consensus document on the use of [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.

Revista espanola de medicina nuclear e imagen molecular·2026

18F-FDG PET/CT metabolic parameters-derived prediction model for microsatellite instability in colorectal cancer.

Revista espanola de medicina nuclear e imagen molecular·2026

Utility of total gastrointestinal transit scintigraphy in the evaluation of patients with VEDOSS and systemic sclerosis.

Revista espanola de medicina nuclear e imagen molecular·2026

Comparative detection performance of PET and conventional scintigraphy tracers for inflammation and infection in bone and soft tissue: A systematic review and network meta-analysis.

Revista espanola de medicina nuclear e imagen molecular·2026

Duration of levothyroxine discontinuation and pre-radioiodine TSH levels in thyroid cancer.

Revista espanola de medicina nuclear e imagen molecular·2026

Persistent fibroblast-related tissue activity in long COVID after moderate-to-severe acute COVID-19 assessed by [⁶⁸Ga]Ga-FAPI PET/CT.

Revista espanola de medicina nuclear e imagen molecular·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us